Tech Company Financing Transactions

Senti Biosciences Funding Round

On 1/7/2021, Senti Biosciences raised $105 million in Series B financing from Leaps by Bayer, 8VC and Amgen Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

2 Corporate Dr. 1st Floor 750
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.sentibio.com

Email Address

[email protected]

Overview

Senti Biosciences is a team of bioengineers, scientists, and entrepreneurs on a mission to treat the most complex and challenging diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Timothy Lu

        

Chief Financial Officer

Curt Herberts

        

Chief Medical Officer

Jose´ Iglesias

        

Chief Operating Officer

Philip Lee

        

Chief Scientific Officer

Gary Lee

        

Co-Founder

James Collins

        

Co-Founder

Wilson Wong

        

Browse more venture capital transactions:

Prev: 1/7/2021: Revelation Biosciences venture capital transaction
Next: 1/7/2021: mindzie venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary